A new standard in reproducibility
The Global Biological Standards Institute has determined that material and procedural standards are the key battleground for improving the reproducibility of preclinical studies-an area of growing concern among funding agencies and industry stakeholders.1-4 This year the institute will form task forces that will begin developing standards in research areas in which the institute deems they are most needed, such as human cancer cell lines, antibody reagents and next-generation genome sequencing.
GBSI was founded in 2012 to catalyze the development and use of biological standards to enhance the reproducibility of basic and translational life sciences research. The organization's scientific advisory council (SAC) includes representatives from academia, industry, publishers and the NIH's National Center for Advancing Translational Sciences (NCATS)...